Latest Research in Immune responses and vaccinations
44 research papers · 2026 median publication year
Top Research Topics in Immune responses and vaccinations
- Respiratory viral infections research — 24 papers
- Pneumonia and Respiratory Infections — 4 papers
- Immune responses and vaccinations — 2 papers
- Vaccine Coverage and Hesitancy — 2 papers
- Liver Disease and Transplantation — 1 papers
- Influenza Virus Research Studies — 1 papers
- Chronic Obstructive Pulmonary Disease (COPD) Research — 1 papers
- Interpreting and Communication in Healthcare — 1 papers
- SARS-CoV-2 and COVID-19 Research — 1 papers
- Ultrasound in Clinical Applications — 1 papers
Highest-Cited Papers
- Characteristics of ascitic fluid and diagnosis of bacterial peritonitis in malignant ascites: An observational study
- Niche-specific immune and microbial signatures across the healthy upper respiratory tract mucosa
- Beyond a One‐Size‐Fits‐All Approach: RSV Vaccination in Immunocompromised Patients
- Reactogenicity and Immunogenicity of RSV Vaccines in Immunocompromised Individuals With Hematological Malignancies
- TCR β CDR3 repertoire profiling identifies pathogen-associated clonal expansions and candidate immune signatures in pediatric Mycoplasma pneumoniae pneumonia
- Integrated proteomics and metabolomics reveal novel biomarkers and metabolic pathways in drug-resistant mycoplasma pneumoniae pneumonia
- A Live Single-Cycle RSV Vaccine with Immune Responses Focused on Prefusion F and the Central Conserved Region of Attachment Protein G
- Vaccine- and infection-induced pneumococcal and DENV-NS1 antibodies reveal differential transplacental transfer and maternal–infant early exposure burden
- Respiratory Syncytial Virus–Related Hospitalizations Among Infants Receiving Nirsevimab
- Detection of a Nirsevimab-Resistant RSV-B Variant (F:K68Q) in an Adult with Severe Infection
- Bridging soil health and human health: Mycobacterium vaccae as a keystone link
- Pharmacokinetics, Safety, and Exploratory Efficacy of Onradivir in Children with Acute Uncomplicated Influenza: A Multicenter, Dose-Ranging, Phase 2 Study
- RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants
- Predictors of Critical Illness During Different COVID-19 Pandemic Periods Compared With Seasonal Influenza
- Real-World Effectiveness of Nirsevimab Against RSV-LRTI and Bronchiolitis Hospitalization: Results from the 2024–2025 Italian Universal Immunization Campaign in Newborns
- Evaluation of Respiratory Syncytial Virus Prefusion F IgG Antibodies in Japanese Mother–Infant Pairs Following Maternal Abrysvo Vaccination and in Infants Hospitalized with RSV Infection
- Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review
- Airway and Gut Dysbiosis, Infectious Exacerbations and Pulmonary Vascular Remodelling in COPD-Associated Pulmonary Hypertension: Microbial Mechanisms, Causal Uncertainty and Therapeutic Implications
- Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis
- Clesrovimab, a monoclonal antibody for the prevention of respiratory syncytial virus disease in infants: a drug profile